For: | Liu M, Luo C, Xie ZZ, Li X. Treatment of gastric hepatoid adenocarcinoma with pembrolizumab and bevacizumab combination chemotherapy: A case report. World J Clin Cases 2022; 10(16): 5420-5427 [PMID: PMC9210915 DOI: 10.12998/wjcc.v10.i16.5420] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v10/i16/5420.htm |
Number | Citing Articles |
1 |
Ming Li, Yan-Xia Mei, Ji-Hang Wen, Yu-Rong Jiao, Qiang-Rong Pan, Xiang-Xing Kong, Jun Li. Hepatoid adenocarcinoma—Clinicopathological features and molecular characteristics. Cancer Letters 2023; 559: 216104 doi: 10.1016/j.canlet.2023.216104
|
2 |
|
3 |
Yi-Jun Mo, Li-Na Lin, Jing-Li Tao, Tao Zhang, Jian-Hua Zhang. Hepatoid adenocarcinoma of the lung: A case report. World Journal of Clinical Cases 2024; 12(21): 4813-4819 doi: 10.12998/wjcc.v12.i21.4813
|
4 |
Chuang Jiang, Zhi-Hong Zhang, Jia-Xin Li. Consideration on immunotherapy of liver metastases of malignant tumors. World Journal of Gastrointestinal Surgery 2024; 16(8): 2374-2381 doi: 10.4240/wjgs.v16.i8.2374
Abstract(237) |
Core Tip(229) |
Full Article(HTML)(815)
|
Full Article with Cover (PDF)-855K(44)
|
Full Article (Word)-48K(1)
|
Audio-892K(3)
|
Peer-Review Report-217K(23)
|
Answering Reviewers-51K(22)
|
Full Article (PDF)-420K(47)
|
Full Article (XML)-173K(23)
|
Times Cited (0)
|
Total Visits (1928)
|
Open
|